Loading company…
Riskpilot
← Back to search
Sign in
Get full access
KinexaTherapeutics ApS
APS
Active
CVR 43952633
Fruebjergvej 3
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2023
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -276K
+2111% vs 2023
EBITDA margin
100.0%
-2111% vs 2023
Equity ratio
-384.7%
Financial strength
Net profit 2024
DKK -286K
-2190% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK -276K
+2111%
EBITDA
DKK -276K
-2111%
Net profit
DKK -286K
-2190%
Total assets
DKK 67K
+70%
Equity
DKK -259K
-1041%
Employees
—
—
Company information
Legal name
KinexaTherapeutics ApS
CVR number
43952633
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
28. marts 2023
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening
Company purpose
Selskabets formål er at drive virksomhed relateret til lægemiddelforskning samt anden, efter direktionens skøn, beslægtet virksomhed.
Contact
Address
Fruebjergvej 3
Phone
+4540180041
Email
mb@copenhagenpatents.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
-12
-276
Staff expenses
-0
-0
EBITDA
-12
-276
Depreciation & amort.
-0
-0
EBIT
-12
-276
Net financials
0
-1
Profit before tax
-12
-277
Tax
-0
9
Net profit
-12
-286
Balance sheet
DKK thousands
Item
2023
2024
Total assets
40
67
Equity
28
-259
Long-term debt
0
251
Short-term debt
12
66
Total debt
12
317
Financial ratios
5-year trend
EBITDA margin
-27634700.0%
This company
15.8%
Market median
-174903265% vs market
2023
2024
Equity ratio
-384.7%
This company
38.2%
Market median
-1107% vs market
2023
2024
Return on equity
-28624500.0%
This company
18.4%
Market median
-155568035% vs market
2023
2024
Net profit margin
-28624500.0%
This company
8.1%
Market median
-353388989% vs market
2023
2024
Asset turnover
-4.11×
This company
1.12×
Market median
-467% vs market
2023
2024
Debt / equity
1.26×
This company
0.62×
Market median
-103% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-03-28 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
MB
Mikkel Bender
Management
Management
2023
—
—
LJ
Lars Jørgensen
Management
Management
2023
—
—
RR
Rune Risgaard
Chief Executive Officer
Chief Executive Officer
2023
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
CORIS Holding ApS
Company
33.3%
33.3%
2023
MEVA HOLDING ApS
Company
33.3%
33.3%
2023
LAJOVI Holding ApS
Company
33.3%
33.3%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
MEVA HOLDING ApS
KinexaTherapeutics ApS
(this company)
Board network connections
Board members of KinexaTherapeutics ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Mikkel Bender
Management
0 companies
Lars Jørgensen
Management
0 companies
Rune Risgaard
Chief Executive Officer
0 companies